SCHEMBL7344801

SCHEMBL7344801

COc1ccc2[nH]c(C)c(C(C)=O)c2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.67
AKR1C2 P52895 1/20 0.59
MTNR1A P48039 2/20 0.56
MTNR1B P49286 2/20 0.56
KDM4E B2RXH2 6/20 0.56
MAPT P10636 4/20 0.56
HSD17B10 Q99714 2/20 0.56
MEN1 O00255 1/20 0.56
TSHR P16473 1/20 0.56
GFER P55789 1/20 0.56
KMT2A Q03164 1/20 0.56
NPC1 O15118 2/20 0.54
HPGD P15428 2/20 0.53
USP2 O75604 1/20 0.52
MAPK1 P28482 1/20 0.52
GAA P10253 2/20 0.51
HTR1D P28221 2/20 0.51
HTR6 P50406 2/20 0.51
POLB P06746 1/20 0.51
TDP1 Q9NUW8 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1434196 0.88 ALDH1A1 (0.67) ALDH1A1AKR1C2MTNR1AMTNR1BKDM4E
SCHEMBL30523119 0.86 ALDH1A1 (0.65) ALDH1A1AKR1C2MTNR1AMTNR1BKDM4E
SCHEMBL18919114 0.86 ALDH1A1 (0.65) ALDH1A1AKR1C2MTNR1AMTNR1BKDM4E
SCHEMBL8877634 0.85 ALDH1A1 (0.61) ALDH1A1AKR1C2MTNR1AMTNR1BKDM4E
SCHEMBL9959282 0.84 ALDH1A1 (0.62) ALDH1A1AKR1C2MTNR1AMTNR1BKDM4E
SCHEMBL31543702 0.84 ALDH1A1 (0.62) ALDH1A1AKR1C2MTNR1AMTNR1BKDM4E
SCHEMBL31543737 0.84 ALDH1A1 (0.62) ALDH1A1AKR1C2MTNR1AMTNR1BKDM4E
SCHEMBL21330596 0.83 NQO2 (0.57) ALDH1A1AKR1C2MTNR1AMTNR1BKDM4E
SCHEMBL4720481 0.82 GAA (0.71) ALDH1A1AKR1C2KDM4EMAPTHSD17B10
SCHEMBL5110673 0.82 ALDH1A1 (0.61) ALDH1A1AKR1C2MTNR1AMTNR1BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10815222-B2 Compounds for use in the treatment of kinetoplastid infection C.N.C.C.S. S.C.A.R.L. COLLEZIONE NAZIONALE DEI COMPOSTI CHIMICI E CENTRO SCREENING (IT) 2020-10-27 US disclosed
US-20200095232-A1 COMPOUNDS FOR USE IN THE TREATMENT OF KINETOPLASTID INFECTION C.N.C.C.S. S.C.A.R.L. COLLEZIONE NAZIONALE DEI COMPOSTI CHIMICI E CENTRO SCREENING (IT) 2020-03-26 US disclosed
WO-2016014426-A1 ORGANIC REACTIONS THE ARIZONA BOARD OF REGENTS (US) 2016-01-28 WO disclosed
US-5112846-A Nonsteroidal antiinflammatory agents WARNER-LAMBERT COMPANY (US) 1992-05-12 US disclosed
US-5075330-A N-hydroxyamide, N-hydroxythioamide, N-hydroxyurea, and N-hydroxythiourea derivatives of selected NSAIDS as antiinflammatory agents WARNER-LAMBERT CO. (US) 1991-12-24 US disclosed
US-4981865-A N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents WARNER-LAMBERT CO. (US) 1991-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10815222-B2 Compounds for use in the treatment of kinetoplastid infection NISCH, TK2, FDPS ALDH1A1 1658/4885AKR1C2 1158/4885MTNR1A 4699/4885
US-20200095232-A1 COMPOUNDS FOR USE IN THE TREATMENT OF KINETOPLASTID INFECTION NISCH, TK2, FDPS ALDH1A1 1658/4885AKR1C2 1158/4885MTNR1A 4699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.